Drug Substance Manufacturing

Supporting Clinical as well as Commercial Requirements

All Clinical Drug Substance cGMP manufacturing will require a cell line with a robust upstream and downstream process to support Phase I and Phase II clinical studies

All Late Stage and Commercial Drug Substance cGMP manufacturing programs will require scale-down Proccess Validation and PPQ runs with established
upstream and downstream processes

We will help you navigate the selection of the correct CDMO partner for your programs